Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 5:16 pm Sale |
2022-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 0 0.000% |
-1,472,522 (Position Closed) |
Filing History |
| 2023-02-07 06:01 am Purchase |
2023-01-19 | 13G | Advaxis, Inc. ADXS |
Harel Insurance Investments & Financial Services Ltd | 403,523 8.300% |
403,523 (New Position) |
Filing History |
| 2023-02-06 2:49 pm Sale |
2022-12-30 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-710,235 (Position Closed) |
Filing History |
| 2023-01-23 4:29 pm Sale |
2023-01-19 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Schindel Yair Chaim | 0 0.000% |
-2,991,473 (Position Closed) |
Filing History |
| 2023-01-09 06:51 am Unchanged |
2022-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Schindel Yair Chaim | 2,991,473 20.180% |
0 (Unchanged) |
Filing History |
| 2022-10-31 4:00 pm Unchanged |
2022-10-19 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Novartis Institutes for BioMedical Research Inc. | 698,777 4.700% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 1,472,522 9.900% |
91,445 (+6.62%) |
Filing History |
| 2022-02-04 09:15 am Sale |
2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
WELLINGTON MANAGEMENT CO LLP | 710,235 5.100% |
-45,120 (-5.97%) |
Filing History |
| 2022-01-31 10:58 am Sale |
2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Harel Insurance Investments & Financial Services Ltd | 2,153,272 15.500% |
-10,562 (-0.49%) |
Filing History |
| 2022-01-24 06:10 am Unchanged |
2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Schindel Yair Chaim | 2,991,473 21.470% |
0 (Unchanged) |
Filing History |
| 2021-03-02 4:10 pm Purchase |
2021-02-23 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 1,381,077 9.990% |
713,261 (+106.81%) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 667,816 5.200% |
667,816 (New Position) |
Filing History |
| 2021-02-08 1:54 pm Purchase |
2020-05-12 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Israel Biotech Fund I L.P. | 3,315,119 25.900% |
3,315,119 (New Position) |
Filing History |
| 2021-02-08 06:01 am Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Schindel Yair Chaim | 2,991,473 23.410% |
2,991,473 (New Position) |
Filing History |
| 2021-02-05 5:17 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Novartis Institutes for BioMedical Research Inc. | 698,777 5.500% |
698,777 (New Position) |
Filing History |
| 2021-02-03 2:14 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
WELLINGTON MANAGEMENT CO LLP | 755,355 5.910% |
755,355 (New Position) |
Filing History |
| 2020-05-14 8:30 pm Purchase |
2020-05-12 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Harel Insurance Investments & Financial Services Ltd | 2,163,834 17.400% |
2,163,834 (New Position) |
Filing History |